Skip to main content

Table 1 Expression profiles of genes related to human cancer drug resistance and metabolism showing at least 20-fold change in expression

From: Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells

Symbol

GenebankID

Incease

Gene name

ABCB1

NM_000927

122.73

ABC20,CD243,CLCS,GP170,MDR1,MGC163296,P-GP,PGY1

APC

NM_000038

27.25

BTPS2,DP2,DP2.5,DP3,GS

ATM

NM_000051

27.35

AT1,ATA,ATC,ATD,ATDC,ATE,DKFZp781A0353,MGC74674,TEL1,TELO1

BRCA2

NM_000059

34.61

BRCC2,BROVCA2,FACD,FAD,FAD1,FANCB,FANCD,FANCD1

CDKN2A

NM_000077

2689.53

ARF,CDK4I,CDKN2,CMM2,INK4,INK4a,MLM,MTS1,TP16,p14,Prop14ARF,p16,p16INK4,p16INK4a,p19

CYP2B6

NM_000767

−39.27

CPB6,CYP2B,CYPIIB6,IIB1,P450

CYP2C19

NM_000769

−145.20

CPCJ,CYP2C,P450C2C,P450IIC19

PPARG

NM_015869

−29.31

CIMT1,NR1C3,PPARG1,PPARG2,PPARgamma